Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-16

Clinical Trial Update: Oral and Topical Tranexamic Acid for the Treatment of Melasma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral and topical tranexamic acid for melasma, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Centro Dermatológico Dr. Ladislao de la Pascua | Conditions: Melasma, Chloasma | Phase 3 | Status: UNKNOWN